Dermatology · San Antonio, TX
NPI
1528294055
Since 2009
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10603 West Ave
San Antonio, TX, 78213
Phone (210) 901-9353
Groups this clinician bills Medicare through
Medicare paid, 2024
$303K
4,977 services
Medicare patients, 2024
535
Average age 75
Drug cost, 2024
$1.6M
1,875 prescriptions
Company payments, 2025
$140K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lindsey B Finklea was code 17003 (destruction skin lesion), 1,363 times for 218 patients. In total Lindsey B Finklea billed 4,977 services in 61 codes, and Medicare paid $303K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,363 | 218 | $4.67 | $6,362 |
| 99213 Office E&M - Established | Office | 482 | 327 | $57.17 | $28K |
| 17000 Destruction Skin Lesion | Office | 359 | 263 | $30.91 | $11K |
| 17110 Destruction Skin Lesion | Office | 340 | 264 | $73.32 | $25K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 258 | 38 | $132.34 | $34K |
| 77280 Radiation Treatment Planning | Office | 240 | 35 | $198.32 | $48K |
| 77401 Conventional Radiation Treatment | Office | 231 | 35 | $30.70 | $7,093 |
| 99214 Office E&M - Established | Office | 174 | 125 | $80.62 | $14K |
| 11102 Skin Biopsy | Office | 156 | 139 | $55.07 | $8,591 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 97 | 33 | $0.69 | $66.88 |
| 99203 Office E&M - New | Office | 72 | 72 | $69.86 | $5,030 |
| 11900 Skin | Office | 55 | 29 | $28.20 | $1,551 |
| 11103 Skin Biopsy | Office | 49 | 37 | $36.18 | $1,773 |
| 96372 Injection Administration | Office | 45 | 19 | $9.61 | $433 |
| 77336 Radiation Treatment Planning | Office | 35 | 12 | $65.71 | $2,300 |
By year: 2022 $311K for 5,978 services; 2023 $742K for 6,291 services; 2024 $303K for 4,977 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lindsey B Finklea prescribed most often to Medicare patients was Triamcinolone Acetonide, with 202 prescriptions and refills. In total Lindsey B Finklea wrote 1,875 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 202 | 257 | 127 | $1,815 |
| Ketoconazole Generic | 191 | 218 | 89 | $3,083 |
| Dutasteride Generic | 112 | 173 | 27 | $3,058 |
| Doxycycline Hyclate Generic | 109 | 184 | 45 | $5,922 |
| Betamethasone Dipropionate Generic | 105 | 124 | 71 | $4,632 |
| Clobetasol Propionate Generic | 93 | 102 | 51 | $2,989 |
| Fluconazole Generic | 77 | 163 | 37 | $740 |
| Hydroxyzine Hcl Generic | 56 | 98 | 29 | $464 |
| Spironolactone Generic | 46 | 84 | 13 | $1,019 |
| Fluocinonide Generic | 42 | 43 | 29 | $1,287 |
| Tretinoin Generic | 40 | 44 | 19 | $2,549 |
| Minocycline Hcl Generic | 38 | 50 | 11 | $708 |
| Metronidazole Generic | 38 | 60 | 26 | $3,354 |
| Minoxidil Generic | 38 | 90 | 13 | $405 |
| Dupixent Pen Dupilumab | 37 | 39 | Under 11 | $147K |
Brand drugs: 284 claims; generic drugs: 1,591 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lindsey B Finklea $140K ($138K in general payments such as food, travel and fees and $1,756 for research) from 27 companies. The largest payer was Lilly USA, LLC with $71K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 77 | $71K |
| Galderma Laboratories, L.P. GALD.SW | 36 | $22K |
| Novartis Pharmaceuticals Corporation NVS | 32 | $21K |
| Abbvie Inc. ABBV | 21 | $10K |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $4,484 |
| Organon LLC OGN | 26 | $3,385 |
| LNHC, Inc | 4 | $3,384 |
| Journey Medical Corporation DERM | 2 | $1,125 |
| UCB, Inc. UCB.BR | 15 | $591 |
| Incyte Corporation INCY | 23 | $434 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.